Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inspire Medical SystemsINSP +2.52%54 3-Year Share Buyback Ratio is 0.50 as of Jun. 2026. GuruFocus rates INSP with a GF Score™ of 54/100 and a GF Value™ of $190.54 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 612 Medical Devices & Instruments companies, Inspire Medical Systems ranks better than 88.24% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Inspire Medical Systems's current 3-Year Share Buyback Ratio was 0.50%.
The historical rank and industry rank for Inspire Medical Systems's 3-Year Share Buyback Ratio or its related term are showing as below:
INSP'
s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -26.1 Med: -5.9 Max: 0.5
Current: 0.5
During the past 11 years, Inspire Medical Systems's highest 3-Year Share Buyback Ratio was 0.50%. The lowest was -26.10%. And the median was -5.90%.
INSP's 3-Year Share Buyback Ratio is ranked better than 88.24% of 612
companies
in the Medical Devices & Instruments industry
Industry Median: -2.6
vs INSP: 0.50
Inspire Medical Systems (NYSE:INSP) 3-Year Share Buyback Ratio Explanation
A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Inspire Medical Systems 3-Year Share Buyback Ratio Related Terms
INSP vs CNMD, TNDM, NVCR: 3-Year Share Buyback Ratio Comparison
For the Medical Devices subindustry, Inspire Medical Systems's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems 3-Year Share Buyback Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's 3-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's 3-Year Share Buyback Ratio falls into.
Inspire Medical Systems 3-Year Share Buyback Ratio Calculation
This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Share Buyback Ratio of 0.50 mean?
Inspire Medical Systems (INSP) has a 3-Year Share Buyback Ratio of 0.50 as of Jun. 2026. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #72 out of 612 companies in the Medical Devices & Instruments industry, placing it in the top 11.8%.
Is Inspire Medical Systems' 3-Year Share Buyback Ratio too high?
Inspire Medical Systems' current 3-Year Share Buyback Ratio is 0.50. Based on the distribution chart, Inspire Medical Systems ranks #72 out of 612 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Inspire Medical Systems has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' 3-Year Share Buyback Ratio compare to CNMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #72 out of 612 companies for 3-Year Share Buyback Ratio. This places Inspire Medical Systems in the top 12% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Share Buyback Ratio for a Medical Devices & Instruments company?
A good 3-Year Share Buyback Ratio depends on the Medical Devices & Instruments industry context. However, 3-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Share Buyback Ratio mean?
A high 3-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. View historical data for Inspire Medical Systems and its competitors. Inspire Medical Systems's current 3-Year Share Buyback Ratio is 0.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (INSP) is currently considered Significantly Undervalued. The stock's GF Value™ is $190.54, compared to a current price of $62.99 — trading 66.9% below its estimated fair value. The current 3-Year Share Buyback Ratio is 0.50. Inspire Medical Systems' overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Share Buyback Ratio calculated?
3-Year Share Buyback Ratio is calculated from a company's financial statements. For Inspire Medical Systems (INSP), the current 3-Year Share Buyback Ratio is 0.50 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (INSP) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of $62.99 is trading 66.9% below its estimated GF Value™ of $190.54.
GuruFocus considers Inspire Medical Systems to be Significantly Undervalued.
Key valuation signals for INSP:
3-Year Share Buyback Ratio: 0.50
GF Value™: $190.54 vs. price of $62.99 (66.9% below fair value)
No single metric tells the full story. See the INSP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
54GF Score
Get the complete analysis for INSP
3-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INSP has been successfully added to your 
